As Cipla Battles Roche, Chairman Calls For India National Patent Pool To Lower Drug Prices
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Cipla Chairman Yusuf Hamied - known for his stance against patenting highly priced drugs - has appealed for the creation of a national patent pool, rather than an international patent pool, to combat neglected diseases like HIV, tuberculosis, malaria and diseases prevalent in the developing world
You may also be interested in...
Cipla Questions Patentability Of Roche’s Tarceva In Ongoing Dispute
MUMBAI - The long drawn patent fight in India between Swiss drug giant Roche and Indian generics company Cipla over lung cancer drug Tarceva (erlotinib) is poised for an interesting turn